Showing results (761-770 of 1,395) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|February 1, 2022
Therapeutic Implication of Genomic Landscape of Adult Metastatic SarcomaXiaolan Feng, Erin Pleasance, Eric Y Zhao, et al.
JCO Precision Oncology|February 1, 2022
Tumor Mutational Burden Is Site Specific in Non-Small-Cell Lung Cancer and Is Highest in Lung Adenocarcinoma Brain MetastasesMatthew K Stein, Manjari Pandey, Joanne Xiu, et al.
JCO Precision Oncology|February 1, 2022
Tissue/Site-Agnostic Study of Ribociclib for Tumors With Cyclin D-CDK4/6 Pathway Genomic Alterations: A Phase II, Open-Label, Single-Arm Basket StudyJulio Peguero, Davendra P S Sohal, Bert H O'Neil, et al.
JCO Precision Oncology|February 1, 2022
Atypical RAS Mutations in Metastatic Colorectal CancerFilippo Pietrantonio, Rona Yaeger, Alexa B Schrock, et al.
JCO Precision Oncology|February 1, 2022
Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer GenesEmily W Moody, Jennie Vagher, Whitney Espinel, et al.
JCO Precision Oncology|February 1, 2022
Proposal for Value-Based, Tiered Reimbursement for Tumor Biomarker Tests to Promote Innovation and Evidence GenerationMichaela A Dinan, Gary H Lyman, Richard L Schilsky, et al.
JCO Precision Oncology|February 1, 2022
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR AlterationsDavid M Hyman, Ben Tran, Luis Paz-Ares, et al.
JCO Precision Oncology|March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid TumorsPashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
JCO Precision Oncology|September 3, 2021
Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or CholangiocarcinomaKarthikeyan Murugesan, Radwa Sharaf, Meagan Montesion, et al.
JCO Precision Oncology|April 30, 2021
Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II TrialAlice P Chen, Shivaani Kummar, Nancy Moore, et al.
Pageof 140